Arkolith/Insider Trading/VCNX/Form 4/A

Sanchez Jill

Chief Financial OfficerVACCINEX, INC. (VCNX) · full profile →Form 4/A · filed May 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 21, 2024Grant(A)805—$0805

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001062993-24-010187) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML